The U.S. has provided doses of an experimental antibody drug from Mapp Biopharmaceutical for use in clinical trials to fight the widening Ebola outbreak in Democratic Republic of Congo, a Health Department spokesperson said.
Definium Therapeutics said a single dose of its LSD-based experimental pill significantly reduced symptoms of major depression in patients in a late-stage trial, sending its shares soaring 55% to a more than four-year high on Monday.
U.S. supplies of progesterone are coming under strain, with patients, clinicians, and pharmacists reporting recent intermittent shortages of oral versions of the hormone used in many fertility and menopause treatments.
Resident doctors in England have called off strikes due to start next week after the government made a “last-minute” offer that will be put to a vote of union members, the British Medical Association said on Saturday.
Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients with type 2 diabetes not using insulin, compared with routine care, according to study results.
Around 20 flights carrying medical equipment and specialist staff have landed at a base in Kenya where the U.S. government is continuing to build an Ebola quarantine facility despite protests and Kenyan court orders blocking it, according to flight data and officials.
Daraxonrasib improved symptoms enough that some patients could resume activities they had previously abandoned and a new benchmark for treating the deadly cancer.